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Identity of tumorigenic human urothelial cell lines and 'spontaneously'
transformed sublines
B. Christensen', C. Hansen2, M. Debiec-Rychter5, J. Kieler3, S. Ottensen4 & J. Schmidt
The Fibiger Institute, The Danish Cancer Society, Copenhagen, Denmark.
Summary Restriction fragment length polymorphism (RFLP) analysis, comparative marker chromosome
analysis, and polymorphic enzyme analysis was carried out on a total of eight human urothelial cell lines and
sublines selected according to our knowledge of their HLA-A,B phenotype. RFLP analysis and cytogenetic
analysis showed that the cell lines Hul7O3He, HuI922, and T24 are genuine cell lines of different origin. The
identity of Hul7O3He could not be confirmed by its isozyme phenotype which was identical to the T24
phenotype. RFLP analysis and isozyme analysis revealed that three cell lines, Hu456, Hu549, and Hu961a,
and two transformed sublines, HCV-29Tm. and Hu6O9T,,,,, are sublines of T24. A common origin of Hu456,
Hu549, Hu96la, HCV-29TmV, and Hu6O9TmV was confirmed by marker chromosome analysis. However, the
T24 origin of these cytogenetically related cell lines was not supported by chromosome analysis of T24. RFLP
analysis and HLA phenotyping of two tumorigenic and invasive sublines isolated from a culture of non-
tumorigenic Hu609 cells showed that non-tumorigenic Hu609 cells can transform 'spontaneously' in vitro into
tumorigenic Hu6O9T cells. The results emphasise the need for careful monitoring and screening of cell lines for
their identity using more than one identification parameter.
Human urothelial cell lines propagated in vitro can be
classified into various grades of transformation (TGrI-III)
according to their life span in vitro and tumorigenicity in
nude mice (Christensen et al., 1984). The criteria used for this
classification and the heterogeneity of cell lines belonging to
the same transformation grade (Christensen et al., 1984;
1987; Kieler et al., 1987) will in many cases allow the
identification of individual cell lines. However, the disc-
riminating power of these parameters is not sufficient to
identify the cell lines by their origin and thereby to raise
suspicion in case of cellular cross-contamination.
Expression of polymorphic HLA-A,B epitopes can be used
to identify non-tumorigenic TGrI and TGrII cell lines as
genuine (Ottesen & Kieler, 1991) but not necessarily accord-
ing to their origin (Christensen et al., submitted). HLA-A,B
typing as a means of identification of tumorigenic TGrIII cell
lines however has failed for various reasons, including an
apparent selective loss of HLA-B locus coding antigens
(Ottesen & Kieler, 1991). However, in three cases where the
HLA-A,B phenotype of the donor was known, a shift in the
expression of a class I antigen raised suspicion of cellular
cross-contamination but the origin of these cross-contaminat-
ed cell lines could not be established (Ottesen & Kieler,
1991).
In order to establish the identity of these tumorigenic
human urothelial cell lines we have applied other methods
for cell line identification. These include comparative marker
chromosome analysis, polymorphic enzyme analysis, and
RFLP analysis using a locus specific minisatellite probe that
recognises a PvuII restriction fragment length polymorphism
(RFLP) in the hypervariable region (HVR) 3' to the alpha-
globin gene cluster on chromosome 16 (Reeders et al., 1985).
This region has been shown to be highly polymorphic, and
more than 20 alleles have been described (Higgs et al., 1981;
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Reeders et al., 1985). It consists of a tandem-repeat sequence,
and polymorphism at this locus is attributed to variability in
the number of copies of the elements of the repeat.
Materials and methods
Cells
The cell lines and sublines selected for the present study are
shown in Table I.
The cell lines were stored on several occasions in liquid
nitrogen and they were tested repeatedly for mycoplasma
infection with a negative result (Christensen et al., 1984;
1987). The batches used for the study were selected according
to our knowledge of their HLA-A,B phenotype (Ottesen &
Kieler, 1991; Vilien et al., 1981). We selected one cell line,
Hu96la and two sublines, HCV-29Tmv and HU609TmV, that
by HLA typing were suspected of being cross-contaminated,
two cell lines, Hu1922 and T24, that by the same parameter
were believed to be independent genuine cell lines, and three
cell lines, Hu456, Hu549 and Hul70He, where the identi-
fication by HLA-A,B typing had failed.
T24 was originally established by Bubenik et al. (1973) and
was received in 1973. It expressed the same HLA-A,B pheno-
type as T24 propagated in other laboratories (Ottesen &
Kieler, 1991). The other cell lines were established at the
Fibiger Institute between 1974 and 1984 by different investi-
gators (Don & Kieler, 1980; Vilien et al., 1983; Christensen et
al., 1984; 1987). Hu6O9Tmv and HCV-29Tmv were two sub-
lines originally supposed to be derived by 'spontaneous'
Table I Identity ofhuman urothelial cell lines according to HLA-A,B
phenotyping
HLA-A,B type HLA-A,B
Cell line ofcell linea type ofdonor Identity?
HCV-29Tmv Al; B- A2, B14 Contaminated
HU6O9Tmv Al; B- A2; B5 Contaminated
Hu456 Al; B- Unknown Inconclusive
Hu549 Al; B- Al, 3; B7, 8 Inconclusive
Hu96la Al; B- A2, 25; B7, 18 Contaminated
Hul7O3He Al; B- Unknown Inconclusive
Hu1922 A2, 3; B- Unknown Genuine
T24 Al; B18 Unknown T24C
'Vilienetal.(1981);Ottesen&Kieler(1991).bOttesen&Kieler(1991).
CHLA-A,B typeofdonorunknown but theoriginal T24cell lineexpress
the same epitopes as the T24 cell line in this study (Ottesen & Kieler,
1991).
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transformation of Hu609 and HCV-29, respectively (Vilien et
al., 1983).
All cell lines were propagated routinely in vitro in standard
Fib 41B medium supplemented with seven non-essential
amino-acids and 5-10% heat-inactivated foetal bovine
serum.
Chromosome preparation and analysis
Metaphase arrested chromosomes were prepared as previous-
ly described (Debiec-Rychter et al., 1986). Briefly, meta-
phases were prepared from freshly initiated subcultures of
cells maintained in Fib 41B medium supplemented with seven
non-essential amino acids and 5-10% foetal bovine serum.
The cells were treated with colcemid (0.05 lag ml-') for 2 h
prior to harvest. Cells were harvested from the cultures by
brief trypsinisation, treated with 75 mM KCI for 30 min at
37°C, fixed with methanol:acetic acid (3:1), and spread on
slides. Detailed chromosome analysis was performed by using
G- and C-banding techniques (Arrighi & Hsu, 1980; Sea-
bright, 1971). Chromosomes were described according to the
nomenclature of the International System for Human Cyto-
genetic Nomenclature (ISHCN, 1991).
Polymorphic enzyme analysis
The following polymorphic enzymes were analysed. LDH:
lactate dehydrogenase (EC 1.1.1.27); G6PD: glucose-6-phos-
phate dehydrogenase (EC 1.1.1.49); PGM-l and PGM-3: first
and third loci of phosphoglucomutase (EC 2.7.5.1); ESD:
esterase D (EC 3.1.1.1); Me-2: malate dehydrogenase (EC
1.1.1.40); AK-1: adenylate kinase (EC 2.7.4.3) and GLO-1:
glyoxylase-l (EC 4.4.1.5).
Preparation of cell extracts and electrophoretic separation
of isozymes was done as previously described (Halton et al.,
1983; Ottenbright et al., 1983). Briefly, cell suspensions of at
least 5 x 106 cells were centrifuged and washed twice in PBS.
Following the last centrifugation, the packed cells were resus-
pended in an equivalent volume of PBS and freeze thawed six
times in dry ice and methanol. Cell fragments were removed
by centrifugation and 1- 5 ,l of clarified cell extract was
loaded on agarose electrophoresis films (Corning, NY, USA)
and electrophoresed in a constant voltage cassette system
(Corning, NY, USA). The agarose films, the electrophoresis
buffers and the stain buffers applied for each of the eight
enzyme analysed were as described by Halton et al. (1983).
Restriction fragment length polymorphism (RFLP) analysis
The probe used to detect the RFLP in the HVR 3' to the
alpha-globin gene cluster was the 4 Kb EcoRI/HindIII frag-
ment of p-alpha-3'HVR.64 (Higgs et al., 1981; Reeders et al.,
1985) labelled with 32P by random priming (Feinberg &
Vogelstein, 1983).
High molecular weight DNA was isolated using standard
methods (Maniatis et al., 1982). Isolated DNA was digested
to completion with PvuII (New England Biolabs, Beverly,
MA, USA). Digested DNA was ethanol precipitated, washed
in 70% ethanol and resuspended in TE-buffer (TE = 10 mM
Tris-HCl, 1 mM EDTA, pH 7.4). Electrophoresis was done in
0.6% agarose (Litex, Denmark) at 30-40 V for 12-16 h in
TBE-buffer (0.045 M Tris-borate, 0.001 M EDTA, pH 8.0)
using HindlII digested lambda phage DNA (Boehringer
Mannheim) as a size marker.
Gels were soaked in 0.25 N HCI, 1.5 M NaCl, denatured in
0.15 N NaOH, 1.5 M NaCl, and neutralised in I M Tris-HCl
(pH 8.0), 1.5 M NaCl before the DNA fragments were trans-
ferred to nitrocellulose filters (Schleicher and Schuell, Dassel,
Germany) by Southern blotting (Southern, 1975). After blot-
ting, the filters were rinsed twice in 6 x SSC (1 x SSC =
0.15 M NaCl, 0.015 M sodium citrate, pH 7.0) and baked for
2 h at 80°C. Filters were wetted in 6 x SSC and then prehy-
bridised in 6 x SSC, 5 x Denhardt's (Maniatis et al., 1982),
0.01 M EDTA, 50% formamide, 0.5% SDS; denatured herr-
ing sperm DNA was added to a final concentration of 100 jig
ml-'. Hybridisation was carried out in the same buffer, with
the addition of 3 x 106c.p.m. ml1' of 32P-labelled probe for
16-18h at 45°C.
Filters were washed in 2 x SSC, 0.1% SDS at room temp-
erature for 20 min and then three times in 0.1 x SSC, 0.1%
SDS at 56°C for 20 min. Autoradiography was carried out
for 4-10 days using Kodak X-AR5 film with one intensify-
ing screen.
'Spontaneous' transformation ofnon-malignant Hu6O9 cells
In order to retest the original observation of 'spontaneous'
transformation of the immortalised but non-tumorigenic cell
line Hu609 made by Vilien et al. (1983), a subline of Hu609
stored in liquid nitrogen after 12 passages in vitro was recul-
tivated under conditions that excluded any exposure to con-
tact with other cell lines. 'Spontaneous' transformation was
evaluated by morphological studies, invasiveness into fragments
of co-cultures of embryonic chick hearts, and by tumorigenicity
testing in athymic Balb/c nude mice as previously described
(Christensen et al., 1984). The HLA-A,B phenotype of the
Hu609 cell line and its transformed sublines was determined
as described elsewhere (Ottesen & Kieler, 1991).
Results
Chromosomal markers
Ten to 20 metaphases from each cell line were analysed. A
total of 61 different marker chromosomes were identified
(Table II).
Table III shows the distribution of those chromosomal
markers that are seen in at least 50% of the metaphases
analysed in at least three tumorigenic cell lines. As it is seen
Hu961a which was presumed to be contaminated contained
ten chromosomal markers (m30-m39). Nine of these were
shared by Hu456 and Hu549. One additional marker was
present in two of these three cell lines. Eight of the markers
identified in Hu961a were also present in more than 50% of
the metaphases of HCV-29Tmv and Hu6O9Tmv which was also
Table II Description of marker chromosomes
ml: del(9) (pl3) m32: del(10) (p11)
m2: der(8;13) (qlO;qlO) m33: del(8) (pl 1)
m3: der(l;5) (plO;plO) m34: add(19) (p13.3)
m4: add(7) (q32) m35: del(2) (pl6)
mS: add(5) (pl5) m36: i(2) (plO)
m6: i(21) (qlO) m37: i(8) (qlO)
m7: unknown m38: unknown
m8: add(12) (ql4) m39: del(4) (ql )
m9: add(l) (ql3) m40: del(l) (q21)
mlO: add(l) (q41) m41: add(15) (q26)
ml : add(ll) (plO) m42: del(l) (ql )
m12: der(l;12) (plO;plO) m43: dic(20) (ql2;ql2)
ml3: add(l) (q44) m44: unknown
m14: del(l) (p22) m45: unknown
m1S: del(l) (ql2) m46: unknown
m16: dup(6) (ql3ql5) m47: unknown
m17: i(6) (plO) m48: unknown
m18: del(7) (pl3) m49: unknown
m19: add(8) (p23) m50: unknown
m20: add(13) (pl2) m5l: del(l) (pl2)
m21: add(l5) (p12) m52: unknown
m22: der(7)t(7;16) (p12;q12) m53: i(lO) (qlO)
m23: unknown m54: i(16) (plO)
m24: unknown m55: del(I1) (p11)
m25: unknown m56: unknown
m26: unknown m57: unknown
m27: unknown m58: der(6;17) (plO;qlO)
m28: unknown m59: der(2;14) (plO;qlO)
m29: der(10;14) (qlO;qlO) m60: add(5) (q35)
m30: add(15) (q21) m61: der(5;21) (qlO;qlO)
m31: del(9) (p113), 9qh+
m49: CBG-bandingdisplayed a fine positive band at theend ofthe long
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Table III Distribution of chromosomal markers in tumorigenic
urothelial cell lines
No. ofunique T24 456 549 961a 29T 6097J1703He 1922
markers: 6a 0 0 2b 4C 0 16d le
Markers shared:
Marker no.
m30 + + + + + + - -
m3lt - + + + + + - -
m32 - + + + + + - -
m33tt - + - + + + - -
m34 - + + + + + - -
m35 - + + + +
m36 - + + + + +
m37t - + + + -
m38t - - + + - +
m39 - + + + + +
*TmV sublines. 'ml-m6; bm7-m8; Cm9-ml2; dm13-m28; em29.
tAlso presentin lessthan 50% oftheT24metaphases. ttAlsopresent in
lessthan 10% ofthemetaphases from Hu1922andT24. tAlsopresent in
less than 50% of the Hu549 metaphases.
presumed to be contaminated. Thus, cytogenetically Hu961a,
Hu456, Hu549, HCV-29Tmv and Hu6O9Tmv seem to be closely
related cell lines.
Out of the ten marker chromosomes seen in Hu961a,
marker m30 was also found in at least 50% of the T24
metaphases. In addition, m31, m33 and m37 were seen in less
than 50% of the T24 metaphases. The T24 cell line however
distinguished itself from the five related cell lines and sublines
by the complete absence of six of the commonly shared
markers and the presence of six specific markers (ml-m6).
These specific markers were present in 60-90% of the
analysed T24 metaphases.
Few of the markers identified in the five related cell lines
and in T24 were found in the cell lines Hu1922 and
Hul7O3He. Hu1922 determined to be genuine according to
HLA-A,B phenotype was characterised by two marker
chromosomes. One of these (m29) was specific for Hu1922
and was present consistently. The other marker (m33) which
was present in less than 10% of the Hu1922 metaphases was
also identified in four of the five closely related cell lines in
more than 50% of the metaphases and in T24 in less than
10% of the metaphases (Table III). In Hul7O3He 16 unique
markers were identified (ml3-m28). Twelve of these were
seen in more than 50% of the metaphases analysed. In
addition to the unique markers, Hul703He also contained
two markers (ml8 and m40) identified in HCV-29Tmv,
Hu6O9Tmv, Hu456, Hu549 and T24 in less than 50% of the
analysed metaphases.
Male sex chromosome
Chromosome Y was absent in six cell lines and present in
two cell lines. Four of the cell lines lacking chromosome Y
were derived from male donors. These cell lines (Hu961a,
HCV-29Tmv, Hu456 and Hu549) belonged to the group of
cytogenetically related cell lines. T24 originated from a
female and no Y chromosome was identified in this cell line.
The two cell lines containing a Y chromosome were
Hul703He and HuI922. In these two cell lines the Y
chromosome was present in all metaphases analysed.
Polymorphic enzymephenotype
All cell lines were found to display the human type of LDH,
type B of G6PD, and type 1 of AK-1 (Table IV). Analysis of
five other isozymes allowed the distinction of the genuine cell
line Hu1922 from the remaining cell lines, indicating that this
cell line is different in origin from the other cell lines studied.
Hu456, Hu549, Hu961a, HCV-29Tmv and Hu6O9Tmv which
by marker chromosome anaylsis were suspected to be closely
related and possibly of the same origin showed the same
isozyme profiles except for Me-2 which could not be detected
in HCV-29Tmv and Hu6O9Tmv. A similar profile was also
Table IV Polymorphic enzyme phenotype of human urothelial cell
lines
Cell line LDH G6PD AK-I PGM-1 PGM-3 ESD Me-2 Glo-i
Hu6O9Tmv Hum B 1 1 1 1 0 1
HCV-29TmV Hum B 1 1 1 1 0 1
Hu456 Hum B 1 1 1 1 1 -2 1
Hu549 Hum B 1 1 1 1 1 -2 1
Hu96Ia Hum B 1 1 1 1 1-2 1
T24 Hum B 1 1 1 1 1-2 1
Hul703He Hum B 1 1 1 1 1-2 1
Hu1922 Hum B 1 1-2 1 1 1 1-2
Hum = human; 0 = not detectable.
shown by T24 and by Hul703He both of which differed from
the other cell lines by marker chromosome analysis.
Restrictionfragment length polymorphism (RFLP)
The allelic pattern of the individual cell lines was observed
repeatedly regardless of the passage or clone number analys-
ed, indicating the stability of the locus.
Hul7O3He and Hu1922 both exhibited a distinct heterozy-
gous allelic pattern (Table V). Hu6O9Tmv, HCV-29Tmv,
Hu456, Hu549 and Hu96la suspected to be of the same
origin by marker chromosome analysis all showed one allele
of 3.7 Kbp. This allele co-migrated with a homo- or
hemizygous allele of T24, suggesting that these six cell lines
are of the same origin.
'Spontaneous' transformation ofnon-malignant Hu609 cells
The fidelity of the transformed sublines was tested by HLA-
A,B phenotyping and by RFLP analysis. The results of these
studies are summarised in Table VI.
The parent cell line (Batch: JK 2014) showed the charac-
teristic type 1 morphology (Christensen et al., 1984). It was
non-tumorigenic, expressed polymorphic HLA-A2,B5, and
showed a heterozygous RFLP pattern with bands corre-
sponding to 2.4 and 2.6 Kb. In its 23rd passage subline B
was isolated by single cell cloning and recloning, while the
uncloned parent cell line was continued as cell line Hu609/A.
In the 30th passage a subculture (A3) of Hu609/A showed
morphological alterations and the cells produced regressively
growing tumours in athymic nude mice. Two passages later a
positive invasion test was obtained, and from the invaded
heart tissue a tumorigenic subline (Hu6O9T/A3) could be
isolated. This subline showed the same HLA-A,D phenotype
and RFLP pattern as the original non-tumorigenic Hu609
cell line.
A subline derived from the cloned Hu609/B cell line show-
ed morphological alterations in the 35th to 40th passage.
Table V Fragment sizes ofgenomic DNA from human urothelial cell
lines digested with PvuII and probed with p-alpha-3'HVR.64
Cell line Fragment size (Kbp)
Hu456 3.7
Hu549 3.7
Hu961a 3.7
HCV-29Tmv 3.7
Hu6O9Tmv 3.7
T24 3.7
T24A 3.7
T24B 3.7
Hu1-703He 2.4/3.3
Hu1922 2.4/3.0
T24A and T24B were two sublines with low and high level of
tumorigenicity derived from T24. Separation of the two sublines was
achieved by injection of T24 cells through the ureter into a mouse
urinary bladder suspended in an organ culture chamber (V. Tromholt,
personalcommunication). The T24B sublinewas isolated fromT24cells
that had penetrated themouse bladderwall and plated on thebottom of
the culture chamber. The T24A subline was isolated from T24 cells
remaining in the bladder.882 B. CHRISTENSEN et al.
Table VI 'Spontaneous' malignant transformation of Hu609 cells in vitro
Hu6O9
Batch: JK2014
(13)
(16)* HLA:A2,B5
(19)* Tum (-)
(23)* HLA:A2,B5
uncloned: A3 B3: cloned
(26)
Tum (-)(27) HLA:
A2,B5
Tum (t) (30)
-Inv (t) (32)
(33)**
Tum -
Tum -
Tum -
HLA: A2,B5
(35) Tum (T)
(40) Tum (t)
(41) (41) **
(45) (45) ** Tum t
HLA: (A2),(B5)
Inv t
(48) (Hu6O9T/B3)
(69)
*Alpha-globin 3'-HVR bands corresponding to 2.4 and 2.6 Kbp. **Alpha-globin 3'-HVR bands and
DNA 'fingerprint' identical with original cell line. (A2): HLA-A2 reduced. (B5): HLA-B5 reduced. Tum
- = non-tumorigenic in nude mice. Tum (t) = regressive tumourgrowth in nude mice. Tum t = progres-
sive tumour growth in nude mice. Inv t = positive invasion test in vitro.
These cells were able to produce regressively growing
tumours in athymic nude mice. One of these tumours was
re-explanted before complete regression. After re-cultivation
for four additional passages the Hu6O9T/B3 cells showed a
clear tumorigenic and invasive potential. The fidelity of this
subline was confirmed by its RFLP pattern and by HLA
typing. Thus, the apparently spontaneous transformation of
Hu609 into malignant Hu6O9T cells was confirmed.
Discussion
The purpose of this study was to establish the identity of
tumorigenic urothelial cell lines and sublines by applying
RFLP analysis, isozyme analysis, and comparative marker
chromosome analysis.
The RFLP pattern of Hu1922 and Hul703He showed that
these two cell lines were different in origin from each other
and from other cell lines and sublines analysed, including
non-tumorigenic cell lines (Christensen et al., submitted). The
identity of Hul703He was confirmed by marker chromosome
analysis, but not by its isozyme pattern which was identical
to T24, Hu96la, Hu456, Hu549, HCV-29Tmv, and Hu609Tmv.
The identity of Hu1922 was confirmed by isozyme analysis.
The presence of only two marker chromosomes in Hu1922
made chromosome analysis less suitable for the identification
of this cell line.
Marker chromosome analysis suggests that Hu456, Hu549,
Hu96la, HCV-29Tmv, and Hu6O9Tmv are closely related and
probably of the same origin. By the same parameter T24
distinguished itself from the five related cell lines. The five
related cell lines shared a total of eight chromosomal
markers, but only one of these was found to be characteristic
of T24. However, the identical RFLP pattern of T24 and the
five cytogenetically related cell lines indicates that these six
cell lines are of the same origin. DNA 'fingerprinting' with
single locus probes and a multilocus probe carried out by ICI
Cellmark diagnostics also revealed identical 'fingerprints' of
T24, Hu456, and Hu549.
A common origin of T24 and the five cytogenetically
related cell lines was also confirmed by their isoenzyme
phenotype. Since this phenotype is similar to the isozyme
phenotype of T24 carried in other laboratories (Ottesen &
Kieler, 1991), and since T24 has also been shown to express
the same HLA phenotype as T24 carried in other laboratories
(Ottesen & Kieler, 1991), these observations strongly indicate
that Hu456, Hu549, Hu96la, HCV-29Tmv, and Hu6O9Tmv are
sublines of T24. Contamination of Hu456 and Hu96la with
T24 has previously been suggested by O'Toole et al. (1983)
using HLA-A,B typing and isozyme phenotype, and by
Masters et al. (1988) using a locus specific minisatelite probe
that gave an identical heterozygous pattern by Southern blot
analysis of HinJI digested genomic DNA isolated from T24,
Hu456 and Hu96la.
Hu961a was the first cell lines to raise suspicion of con-
tamination. It was believed to originate from the same
tumour as the non-malignant TGrI cell line, Hu961b. It was
isolated in the fifth passage (Don & Kieler, 1980), and
Hu961a and b were then considered to be a malignant and a
non-malignant variant of a mixed cell population derived
from the same tumour. However, the present study raises the
question, whether Hu96la was derived from T24 by cellular
cross-contamination. If this is the case then T24 must be
considered to be less stable cytogenetically than its five sub-
lines or the T24 contaminant may be a rare cytogenetic
variant transferred to other cell lines through the original
contamination of Hu96la. Chromosome analysis of different
passages of T24 does not support the assumption of chromo-
somal instability being characteristic of T24. Consequently,
contamination of Hu961 with a rare variant of T24 and
subsequent contamination of Hu456, Hu549, Hu6O9 or
Hu6O9Tmv, and HCV-29 or HCV-29Tmv with Hu96la seems
to be the best explanation that may be offered for the present
findings.
Passage
(No)
(34)
Batch A3
HLA:A2, (B'
Tum t
(Hu6O9T/A3
5)
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T24 has been shown to distinguish itself from the five
cytogenetically related cell lines by the expression of HLA-
B18 in addition to HLA-Al which is the only epitope ex-
pressed by HCV-29Tmv, HU6O9Tmv, Hu96la, Hu456 and
Hu549 (Ottesen & Kieler, 1991). The recent observation that
the B18 epitope is only weakly expressed in a high tumori-
genic subline of T24 as compared to a low tumorigenic
subline (Ottesen & Kieler, 1991) demonstrates the existence
of variant subpopulations in the T24 cell line. Thus, the
expression of B18 in T24 does not exclude this cell line as a
contaminant of the five cytogenetically related cell lines.
Variability in tumorigenicity among T24 sublines has pre-
viously been described (Hastings & Franks, 1983; Masters et
al., 1986). It might be speculated, that these differences may
be due to variations in the immunogenicity of the cells,
reflected by changes in cell surface antigen expression (Otte-
sen & Kieler, 1991; Trejdosiewicz et al., 1985).
Southern blot analysis of non-tumorigenic HCV-29 and
Hu6O9 cells classified as TGrII has revealed RFLP patterns
which were different from each other and from T24 (Chris-
tensen et al., submitted). HCV-29Tmv and Hu6O9Tmv were
originally reported to be derived by 'spontaneous' transfor-
mation from these two TGrII cell lines (Vilien et al., 1983).
The RFLP pattern however, showed that HCV-29Tmv and
Hu6O9Tmv were sublines of T24 and not originating from
HCV-29 and Hu6O9, respectively. However, the present study
has not clarified whether the appearance of the T24 pheno-
type and genotype in Hu6O9Tmv and HCV-29Tmv cultures is
due to cross-contamination before or after the 'spontaneous'
transformation of the original TGrII cell lines.
In a retrospective study of a series of Hu6O9 cultures that
developed tumorigenic properties between the 15th to 18th
passage and which showed the appropriate Hu6O9 RFLP
pattern before the 15th passage, it has been shown, that
'spontaneous' transformation of these cultures was due to
contamination with T24 or a related cell line, and in one
culture a mixed Hu6O9/T24 RFLP pattern was seen, indicat-
ing a mixed cell population containing Hu6O9 cells and T24
cells (Christensen et al., submitted). However, Ottesen et al.
(1987) have described the gradual decrease or loss of HLA-
A,B expression in Hu6O9 transforming 'spontaneously' into
tumorigenic Hu6O9TLLH cells. The fidelity of this new trans-
formed subline was confirmed by subsequent HLA typing of
neuraminidase treated cells. In the present study, an Hu6O9
culture remained non-tumorigenic for several passages and
retained the appropriate Hu6O9 HLA-A,B phenotype and
RFLP pattern. From this culture two tumorigenic and
invasive variants with the characteristic Hu6O9 RFLP pattern
were later isolated. The Hu6O9 identity of these two variants
was also confirmed by DNA 'fingerprinting' with a multi-
locus probe carried out by ICI Cellmark diagnostics (Table
VI). From these observations, we conclude that non-
tumorigenic Hu6O9 cells may transform 'spontaneously' in
vitro into tumorigenic Hu6O9T cells. However, whether the
development of the original Hu6O9Tmv subline and the HCV-
29Tmv subline was due to 'spontaneous' transformation or
cross-contamination remains an open question.
In conclusion, the results of this study emphasise the need
for careful monitoring and screening of cell lines for their
identity using more than one identification parameter.
Although the discriminating power of minisatellite probes
seems superior to other identification methods, the data on
the stability of these loci are not yet as extensive as the
literature on HLA typing, polymorphic enzyme loci, and
chromosome analysis. Changes have been observed in DNA
from some samples of tumour tissue, indicating that some of
the loci detected with these probes are unstable during malig-
nant transformation (Thein et al., 1987). Therefore, identifi-
cation by DNA 'fingerprinting' is more ideal than identifica-
tion by a single minisatellite probe.
The present studies were carried out at The Fibiger Institute and at
Michigan Cancer Foundation with the support of The Danish
Cancer Society, the Neye Foundation, the Holm Foundation, and
the Aage V. Jensen Foundation.
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